Sarepta Therapeutics

Hope for Sarepta Drug Approval Found in Obscure FDA Document
TheStreet.com
Tue, 02/23/16 - 05:52 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Sarepta's Duchenne drug decision delayed: Why it could help win approval
Bizjournals.com
Mon, 02/8/16 - 12:47 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
eteplirsen
Will Sarepta reverse after steep drop?
Yahoo/OptionMonster
Sat, 02/6/16 - 12:21 pm
Sarepta Therapeutics
3 Key FDA Decisions Expected in February
24/7 Wall St
Sun, 01/31/16 - 01:38 pm
FDA
Vertex Pharmaceuticals
Kalydeco
Regulus
RG-101
Sarepta Therapeutics
eteplirsen
Why the FDA shouldn’t bow to parental pressure over Duchenne drug
Stat
Tue, 01/26/16 - 09:17 pm
FDA
Duchenne Muscular Dystrophy
drug approvals
Biomarin
Sarepta Therapeutics
Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics
Yahoo/Benzinga
Fri, 01/22/16 - 09:35 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C. Area
Yahoo
Thu, 01/21/16 - 09:38 am
FDA
advisory panels
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics
Four big problems with the FDA’s analysis of Sarepta’s Duchenne drug data
Bizjournals.com
Wed, 01/20/16 - 09:31 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​Duchenne mom: FDA is ‘looking for reasons to deny’ Sarepta’s drug
Bizjournals.com
Fri, 01/15/16 - 02:28 pm
FDA
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Therapeutics' Eteplirsen Likely To Get A Conditional Approval By FDA
Seeking Alpha
Tue, 12/1/15 - 08:54 pm
FDA
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
6 BioHealth Movers That Now Cannot Be Ignored
24/7 Wall St
Sun, 11/22/15 - 01:33 pm
Clovis Oncology
KaloBios
Celladon
Sarepta Therapeutics
Zafgen
Valeant Pharmaceuticals
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Bizjournals.com
Fri, 11/20/15 - 06:19 pm
Duchenne Muscular Dystrophy
FDA
eterplirsen
drisapersen
Biomarin
Sarepta Therapeutics
4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
24/7 Wall St
Fri, 11/20/15 - 11:02 am
Pfizer
Sarepta Therapeutics
PTC Therapeutics
Amag Pharmaceuticals
Experts say Sarepta has a clear edge over BioMarin in Duchenne drug battle
Bizjournals.com
Thu, 11/5/15 - 12:47 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
Pharmalot
Thu, 10/15/15 - 03:59 pm
FDA
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
​Sarepta’s competitor on Duchenne drug could get a two-month head start on sales
Bizjournals.com
Wed, 10/14/15 - 02:23 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biomarin
eteplirsen
drisapersen
Sarepta Therapeutics vs. BioMarin Pharmaceutical: Which Company Will Win the DMD Race?
Motley Fool
Tue, 10/6/15 - 07:13 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Sarepta's Less-Than-Perfect Data
Motley Fool
Mon, 10/5/15 - 11:56 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta gets creative in bolstering its case for quick eteplirsen approval
Fierce Biotech
Thu, 10/1/15 - 09:24 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​Redemption for the drug biz could come next week from Cambridge-based Sarepta
Bizjournals.com
Sun, 09/27/15 - 08:32 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy

Pages